InsidersTradesSigma
Track the DNA X, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 10 February 2026 (Attribution). Among the most active insiders: Crolius Clayton. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
DNA X, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.